Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. HOOD
9. DFTX
10. IBM

Go back to Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q2 EPS by 16c

August 2, 2018 8:05 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($1.61), $0.16 better than the analyst estimate of ($1.77). Revenue for the quarter came in at $29.9 million versus the consensus estimate of $17.97 million.

Guidance:

Alnylam reiterates its expectations to end 2018 with approximately $1.0 billion of cash, cash... More